Activist Al Shams Accuses Braemar Board of Entrenchment with New Nomination Rules
BHR sits 24% above its 52-week low of $2.045.
Summary
Al Shams Investments, Braemar's largest shareholder, accused the company's board of attempting to entrench conflicted insiders by significantly expanding the director nomination questionnaire. This move, adding over 60 questions, is seen by Al Shams as a deliberate tactic to impede shareholder rights and manipulate the election process. This follows Al Shams' recent demands for an immediate annual meeting and criticism of board appointments, escalating an already contentious proxy fight. The outcome of this procedural challenge will be critical for the upcoming 2026 Annual Meeting of Shareholders and the future composition of Braemar's board.
At the time of this announcement, BHR was trading at $2.54 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $174.4M. The 52-week trading range was $2.05 to $3.19. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.